RxDoctor Payments Data

Timothy Bhattacharyya, MD

Orthopaedic Trauma · Bethesda, MDNPI 1902897036

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Medical Device Business Services, Inc. at 28.1% of the total. Reporting peaked in 2023 at $1,079 and has fallen 90.6% since, to $102 in 2025.

$2,779in general payments, 2019–2025

Across 28 payments — averaging $99.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$781
  • Zimmer Biomet$611
  • Philips North America LLC$600
  • Stryker$242
  • Johnson & Johnson$211
  • Globus Medical$206
  • plus $127 from 2 others

What the payments were for

  • Consulting fees$60022%
  • Travel & lodging$68024%
  • Food & beverage$1,39750%
  • Education$1024%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in Marylandto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$349,123
Medicare patients
448
Services billed
1,733

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam27$141
Cephalexin17$64
Tramadol Hcl16$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →